Attempted replication of pharmacogenetic association of variants in PPP1R14C and CCDC148 with aromatase inhibitor-induced musculoskeletal symptoms [0.03%]
尝试重复PPP1R14C和CCDC148变异与芳香化酶抑制剂引起的肌肉骨骼症状的药理遗传相关性研究
Yuqing Liang,Christina L Gersch,Jennifer Lehman et al.
Yuqing Liang et al.
Third-generation aromatase inhibitors (AI) are the standard treatment for patients with hormone receptor positive (HR+) breast cancer. While effective, AI can lead to severe adverse events, including AI-induced musculoskeletal syndrome (AIM...
Common dihydropyrimidinase ( DPYS ) genetic variations do not predict fluoropyrimidine-related chemotherapy toxicity in a Canadian cohort [0.03%]
常见的二氢嘧啶酶(DPYS)基因变异不能预测加拿大人群氟尿嘧啶相关化疗毒性
Samantha J Medwid,Jaymie L Mailloux,Theodore J Wigle et al.
Samantha J Medwid et al.
Known genetic variations in dihydropyrimidine dehydrogenase (gene name DPYD ) do not fully predict patients at risk for severe fluoropyrimidine-associated chemotherapy toxicity. Dihydropyrimidinase (gene name DPYS ), the second catabolic en...
Pharmacogenetics at scale in real-world bioresources: CYP2C19 and clopidogrel outcomes in UK Biobank [0.03%]
大规模真实世界生物资源中的药物遗传学:英国生物银行中CYP2C19和氯吡格雷结局
Khaled F Bedair,Blair Smith,Colin N A Palmer et al.
Khaled F Bedair et al.
Objective: The impact of CYP2C19 genotype on clopidogrel outcomes is one of the most well established pharmacogenetic interactions, supported by robust evidence and recommended by the Food and Drug Administration and clin...
Observational Study
Pharmacogenetics and genomics. 2024 Apr 1;34(3):73-82. DOI:10.1097/FPC.0000000000000519 2024
Nicholas R Boivin,Herolind Jusufi
Nicholas R Boivin
Development of an ARMS multiplex real-time PCR assay for the detection of HLA-B*13:01 genotype by detecting highly specific SNPs [0.03%]
通过检测高度特异性的SNPs用于HLA-B*13:01基因型分型的ARMS-multiplex实时PCR方法的研究开发
Hao Yao,Kaixuan Wang,Sihai Lu et al.
Hao Yao et al.
Objectives: HLA-B*13:01 was strongly associated with Dapsone Hypersensitivity Syndrome (DHS). This study aimed to develop and validate a rapid and economical method for HLA-B*13:01 genotyping. ...
Effect of CYP3A4*22, CYP3A5*3 and POR*28 genetic polymorphisms on calcineurin inhibitors dose requirements in early phase renal transplant patients [0.03%]
CYP3A4*22,CYP3A5*3和POR*28基因多态性对肾移植早期环孢素和他克莫司剂量需求的影响
Abdel-Hameed Im Ebid,Dina A Ismail,Neama M Lotfy et al.
Abdel-Hameed Im Ebid et al.
Objective: This study aimed to investigate the combined effect of CYP3A5*3, CYP3A4*22, and POR*28 genetic polymorphisms on tacrolimus and cyclosporine dose requirements. ...
Cytochrome P4503A4 gene polymorphisms guide safe sufentanil analgesic doses in pregnant Chinese mothers: a multicenter, randomized, prospective study [0.03%]
细胞色素P4503A4基因多态性指导中国孕妇安全的舒芬太尼镇痛剂量:一项多中心随机前瞻性研究
Xiangrong Shu,Yan Yan,Jingxian Yu et al.
Xiangrong Shu et al.
Background: Sufentanil and ropivacaine when used as epidural anesthetics effectively reduce maternal pain during labor. From previous reports, rs2242480 single nucleotide polymorphisms (SNPs) can alter sufentanil metaboli...
Randomized Controlled Trial
Pharmacogenetics and genomics. 2024 Jan 1;34(1):8-15. DOI:10.1097/FPC.0000000000000513 2024
Pharmacogenetics of weight gain following switch from efavirenz- to integrase inhibitor-containing regimens [0.03%]
依非韦伦方案换用整合酶抑制剂治疗后的体重变化的药物基因研究
Kunling Wu,John Koethe,Todd Hulgan et al.
Kunling Wu et al.
Background: Excessive weight gain affects some persons with HIV after switching to integrase strand transfer inhibitor (INSTI)-containing antiretroviral therapy (ART). We studied associations between CYP2B6 genotype and w...
Evaluation of ADRB2 and OATP2A1 genetic polymorphisms in Indian patients with primary open-angle glaucoma [0.03%]
ADRB2和OATP2A1基因多态性在印度原发性开角型青光眼患者中的评估研究
Lakshminarayanan Gowtham,Nabanita Halder,Sundararajan Baskar Singh et al.
Lakshminarayanan Gowtham et al.
The emergence of adrenergic β2-receptor (ADRB2) blockers has revolutionized glaucoma treatment, while the discovery of prostaglandin analogs has further expanded therapeutic options. Organic anion transporting polypeptide 2A1 (OATP2A1/SLCO...
HDL-C and creatinine levels at 1 month are associated with patient 12-month survival rate after kidney transplantation [0.03%]
移植术后患者1个月时的高密度脂蛋白胆固醇和肌酐水平与12个月生存率相关性研究
Haolin Teng,Xinyuan Hu,Nian Liu
Haolin Teng
Background: Many factors affect the survival rate after kidney transplantation, including laboratory tests, medicine therapy and pharmacogenomics. Tacrolimus, mycophenolate mofetil and methylprednisolone were used as an i...